Automated Cell Culture System Market Trends

  • Report ID: 4262
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Automated Cell Culture System Market Trends

Growth Drivers

  • Significant Demand in the Treatment of Skin Problems - In 2022, over 6 million Americans were found to be living with psoriasis while about 200 million were across the globe.

The cell culture system puts regenerative medicines in use for patients practically. Cells are used by regenerative medicines in the form of therapeutic agents which are required for the medical treatment associated with repairing, rebuilding, and making the human body function properly. Hence such a significant utilization is estimated to propel the market growth over the forecast period.

  • Rising Cases of Non-Communicable Diseases - Data published by the World Health Organization showed that nearly 41 million individuals die due to non-communicable diseases every year.
  • Higher Prevalence of Infectious Diseases  - The annual rate of death caused by infectious diseases is estimated to be more than 15 million a year.
  • Growing Healthcare Expenditure Across the Globe - As per the statistics provided by the World Bank, global health expenditure was estimated to reach USD 1,121.9 per capita.
  • Increasing Number of Clinical Trials  - As of 2021, the number of clinical trials is estimated to be nearly 0.4 million in about 200 countries.

Challenges

  • Lack of Skilled Medical Professionals
  • Lack of Required Technology to Develop the Cell Culture System
  • Requirement for Higher Initial Investment

Automated Cell Culture System Market: Key Insights

Base Year

2023

Forecast Period

2024- 2036

CAGR

12.4%

Base Year Market Size (2023)

USD 7.31 Billion

Forecast Year Market Size (2036)

USD 33.39 Billion

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4262
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of automated cell culture system is estimated at USD 8.13 Billion.

The automated cell culture system market size was over USD 7.31 Billion in 2023 and is poised to cross USD 33.39 Billion by the end of 2036, growing at more than 12.4% CAGR during the forecast period i.e., between 2024-2036. Increasing stem cell research & development owing to the higher prevalence of related diseases is estimated to majorly boost the market growth.

North America region will dominate 41% industry share by 2036, attributed to rising investment in research and development in the region.

Hitachi Power Solutions Co, Ltd., Lonza Group Ltd., Thermo Fisher Scientific Company, Cell Culture Company, LLC, Sartorius AG, Becton, Dickinson and Company, Hamilton Company, Merck Group, F. Hoffmann-La Roche AG, Novartis AG
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample